2025 annual financial data
Pacific Biosciences of California 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -69.5%.
Operating income was -557,561,000 USD and net income was -546,376,000 USD.
Operating cash flow was -111,209,000 USD.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 160,005,000 USD
- Operating income
- -557,561,000 USD
- Net income
- -546,376,000 USD
- Operating cash flow
- -111,209,000 USD